Manchester, UK – RTS Life Science, a worldwide supplier of automated sample management and pharmaceutical testing systems, is pleased to announce new US Headquarters and the formation of ‘RTS Life Science LLC’. Following the acquisition earlier this year of Hatch Science, a Massachusetts based life science company, both products and services have now been successfully integrated into the Group.

RTS Life Science LLC is based just south of Boston and is headed up by Martin Schwalm, President and Larry Chin, VP of Sales, North America. With a US team of approximately 20 mechanical, electrical, software, sales and support staff and an impressive design engineering and manufacturing facility, RTS is now able to provide localized sales, engineering and support services to its US client base of sample management, biobanking and pharmaceutical testing customers.

Gary Walsh, CEO of RTS commented. “Our strategy is to strengthen our capabilities in the US which has always represented a substantial part of our business. We now have an extended localized team and have fully integrated our US operations into the business. Our principle objective is to support our customers efficiently and locally and continue to deliver the high standards of service and attention that has become a hallmark of RTS”.

In addition to increasing the product offering and adding manufacturing capabilities, another key factor in the acquisition was in-house product development skills. Having worked together on the development of the RTS Tube Auditor™, RTS Life Science LLC is continuing to work on several other product development initiatives that have recently received RTS investment, including capital, for new machinery and equipment for RTS’ R&D Prototyping Centre.

For further information regarding RTS Life Science or automation solutions for sample management, biobanking or pharmaceutical testing applications contact us at E:Lifescience.info@rts-group.com, call +44 (0) 161 777 2065 (EU) or +1 (508) 673 9524 (US).